Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Intercure Ltd (NQ: INCR ) 2.410 UNCHANGED Streaming Delayed Price Updated: 3:59 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 8,124 Open 2.420 Bid (Size) 2.380 (11) Ask (Size) 2.430 (5) Prev. Close 2.410 Today's Range 2.350 - 2.430 52wk Range 0.9900 - 3.720 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News European Cannabis Companies Race To The Nasdaq: $1B In Tax Break On The Horizon July 18, 2024 Some European cannabis companies are already planning initial public offerings (IPOs) on the Nasdaq, encouraged by the prospect of a less restrictive regulatory environment. The potential rescheduling... Via Benzinga Topics Cannabis Exposures Cannabis Asset-Light Expansion Into $8B German Market Adds Potential To This Cannabis Stock On NASDAQ May 24, 2024 The potential rescheduling of cannabis in the U.S. Via Benzinga Topics Cannabis Exposures Cannabis Performance YTD +84.83% +84.83% 1 Month +22.34% +22.34% 3 Month -8.02% -8.02% 6 Month +95.93% +95.93% 1 Year +51.62% +51.62% More News Read More InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference May 22, 2024 From InterCure Ltd. Via Business Wire InterCure Reports Strong FY2023: Performance Paves the Way for Global Expansion May 02, 2024 Via Benzinga 5 Value Stocks In The Healthcare Sector May 08, 2023 Via Benzinga Overview Of Value Stocks In The Healthcare Sector April 17, 2023 Via Benzinga InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million May 01, 2024 From InterCure Ltd. Via Business Wire This Israeli Cannabis Operator Anticipates $95.4M In Revenue Despite Gaza Conflict April 01, 2024 Via Benzinga Topics Cannabis Exposures Cannabis InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million April 01, 2024 From InterCure Ltd. Via Business Wire InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint March 22, 2024 From InterCure Ltd. Via Business Wire Canndoc Reports Record Revenue Amid Cannabis Market Turmoil September 01, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Stock Movers For August 18, 2023 August 18, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Stock Gainers And Losers From August 24, 2023 August 24, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Stocks That Hit 52-Week Lows On Wednesday July 05, 2023 Via Benzinga Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023 August 21, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Medical Cannabis Company Better Is Suing InterCure For $35M June 15, 2023 Via Benzinga InterCure Stock Trading Lower On Q1 Revenue Growth Of 22%, Here Are The Details May 16, 2023 Via Benzinga Cannabis Stock Gainers And Losers From August 14, 2023 August 14, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Why Are Cannabis Stocks Trading Higher Today? April 27, 2023 Via Benzinga Cannabis Stock Movers For August 10, 2023 August 10, 2023 Via Benzinga Topics Cannabis Exposures Cannabis InterCure Teams Up With TYSON 2.0 In Israel, Australia, United Kingdom, Germany And Other EU Countries April 20, 2023 Via Benzinga Nasdaq Down 80 Points; VirTra Shares Spike Higher April 03, 2023 Via Benzinga Marijuana Stock Movers For August 9, 2023 August 09, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Marijuana Stock Movers For August 8, 2023 August 08, 2023 Via Benzinga Cannabis Stock Movers For July 24, 2023 July 24, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
